Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

Treace Medical Concepts, Inc. (TMCI)

Compare
8.45
+0.08
+(0.96%)
At close: March 28 at 4:00:00 PM EDT
8.45
0.00
(0.00%)
After hours: March 28 at 4:02:29 PM EDT
Loading Chart for TMCI
  • Previous Close 8.37
  • Open 8.32
  • Bid 8.41 x 100
  • Ask 8.49 x 100
  • Day's Range 8.14 - 8.51
  • 52 Week Range 3.92 - 13.24
  • Volume 283,802
  • Avg. Volume 408,228
  • Market Cap (intraday) 529.128M
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) --
  • EPS (TTM) -0.90
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 11.29

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

www.treace.com

477

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TMCI

View More

Performance Overview: TMCI

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TMCI
13.58%
S&P 500 (^GSPC)
5.11%

1-Year Return

TMCI
35.25%
S&P 500 (^GSPC)
6.22%

3-Year Return

TMCI
55.64%
S&P 500 (^GSPC)
21.97%

5-Year Return

TMCI
65.51%
S&P 500 (^GSPC)
119.59%

Compare To: TMCI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TMCI

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    529.13M

  • Enterprise Value

    523.10M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.51

  • Price/Book (mrq)

    4.69

  • Enterprise Value/Revenue

    2.50

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -26.63%

  • Return on Assets (ttm)

    -14.83%

  • Return on Equity (ttm)

    -44.45%

  • Revenue (ttm)

    209.36M

  • Net Income Avi to Common (ttm)

    -55.74M

  • Diluted EPS (ttm)

    -0.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    75.68M

  • Total Debt/Equity (mrq)

    61.70%

  • Levered Free Cash Flow (ttm)

    -30.01M

Research Analysis: TMCI

View More

Company Insights: TMCI

Research Reports: TMCI

View More

People Also Watch